This study explores the association between the Advanced Lung Cancer Inflammation Index (ALI) and 30-day mortality in ICH patients, evaluating its prognostic value as a composite biomarker that integrates body mass index (BMI), serum albumin, and neutrophil-to-lymphocyte ratio (NLR). The gene discussed is ALB; the disease is lung cancer.